Kadsulignan LCAS# 163660-06-8 |
- Neokadsuranin
Catalog No.:BCN7816
CAS No.:115181-68-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 163660-06-8 | SDF | Download SDF |
PubChem ID | 44575997 | Appearance | Powder |
Formula | C23H26O7 | M.Wt | 414.5 |
Type of Compound | Lignans | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC1C(C2C3=CC(=C(C(=C3C4=C(C5=C(C=C4C1O2)OCO5)OC)OC)OC)OC)C | ||
Standard InChIKey | RNIZTMIJCBCDBR-XJSVZPCESA-N | ||
Standard InChI | InChI=1S/C23H26O7/c1-10-11(2)19-13-8-15-21(29-9-28-15)23(27-6)17(13)16-12(18(10)30-19)7-14(24-3)20(25-4)22(16)26-5/h7-8,10-11,18-19H,9H2,1-6H3/t10-,11+,18-,19+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Kadsulignan L shows in vitro antiviral effects on hepatitis B virus. 2. Kadsulignan L shows moderate platelet-activating factor (PAF) antagonistic activities with the IC50 value of 2.6 x 10(-5) M. |
Targets | PAFR | HBV |
Kadsulignan L Dilution Calculator
Kadsulignan L Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4125 mL | 12.0627 mL | 24.1255 mL | 48.2509 mL | 60.3136 mL |
5 mM | 0.4825 mL | 2.4125 mL | 4.8251 mL | 9.6502 mL | 12.0627 mL |
10 mM | 0.2413 mL | 1.2063 mL | 2.4125 mL | 4.8251 mL | 6.0314 mL |
50 mM | 0.0483 mL | 0.2413 mL | 0.4825 mL | 0.965 mL | 1.2063 mL |
100 mM | 0.0241 mL | 0.1206 mL | 0.2413 mL | 0.4825 mL | 0.6031 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Evofolin C
Catalog No.:BCN4695
CAS No.:163634-05-7
- Fmoc-D-Trp(Boc)-OH
Catalog No.:BCC3561
CAS No.:163619-04-3
- Kadsulignan N
Catalog No.:BCN3631
CAS No.:163564-58-7
- Vilazodone
Catalog No.:BCC2040
CAS No.:163521-12-8
- Vilazodone Hydrochloride
Catalog No.:BCC2041
CAS No.:163521-08-2
- Triptoquinonide
Catalog No.:BCN1724
CAS No.:163513-81-3
- Flufenamic acid
Catalog No.:BCC9162
CAS No.:530-78-9
- Fmoc-Met(O2)-OH
Catalog No.:BCC3531
CAS No.:163437-14-7
- 2',4'-Di-O-(E-p-coumaroyl)afzelin
Catalog No.:BCN6512
CAS No.:163434-73-9
- Stachybotrylactam
Catalog No.:BCN6967
CAS No.:163391-76-2
- FIIN-2
Catalog No.:BCC3974
CAS No.:1633044-56-0
- Bethoxazin
Catalog No.:BCC5471
CAS No.:163269-30-5
- Pazufloxacin mesilate
Catalog No.:BCC9114
CAS No.:163680-77-1
- WIN 64338 hydrochloride
Catalog No.:BCC6914
CAS No.:163727-74-0
- Auristatin F
Catalog No.:BCC5522
CAS No.:163768-50-1
- YM 90709
Catalog No.:BCC7149
CAS No.:163769-88-8
- 7beta-Hydroxyrutaecarpine
Catalog No.:BCN6500
CAS No.:163815-35-8
- Salvianolic acid Y
Catalog No.:BCN8123
CAS No.:1638738-76-7
- Androstenediol-3-acetate
Catalog No.:BCC8829
CAS No.:1639-43-6
- 8(17),12E,14-Labdatrien-20-oic acid
Catalog No.:BCN7396
CAS No.:1639257-36-5
- 12E,14-Labdadien-20,8beta-olide
Catalog No.:BCN7395
CAS No.:1639257-37-6
- Kaempferol-3-O-(6''-O-cis-coumaryl)glucoside
Catalog No.:BCN1538
CAS No.:163956-16-9
- Longiferone B
Catalog No.:BCN7378
CAS No.:1639810-67-5
- Clerodenoside A
Catalog No.:BCN1725
CAS No.:164022-75-7
Lignans from Kadsura angustifolia.[Pubmed:11261213]
J Asian Nat Prod Res. 1998;1(2):125-31.
A new dibenzocyclooctadiene lignan named angustifolin D (1) together with four known lignans: Kadsulignan L (2), kadsulignan N (3), schisantherin P (4) and meso-dihydroguaiaretic acid (5) were isolated from the stems of Kadsura angustifolia. Their structures and stereochemistries were elucidated by spectral studies. Compounds 2 and 5 showed moderate platelet-activating factor (PAF) antagonistic activities with IC50 values of 2.6 x 10(-5) and 4.1 x 10(-5) M, respectively.
Dibenzocyclooctane lignans from the stems of Kadsura induta and their antiviral effect on hepatitis B virus.[Pubmed:17511012]
Chem Biodivers. 2007 May;4(5):966-72.
Two new dibenzocyclooctane lignans, kadsurindutins A (1) and B (2), were isolated from the stems of Kadsura induta, together with the known, structurally related lignans schisantherin L (3), schisantherin P (4), Kadsulignan L (5), and neokadsuranin (6). Their structures and configurations were elucidated by spectroscopic methods (UV, ORD, CD, IR, 1D- and 2D-NMR) in combination with mass-spectrometric (HR-MS) techniques. Compounds 1, 5, and 6 showed in vitro antiviral effects on hepatitis B virus.